These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3125787)

  • 21. Carbenicillin resistance of Pseudomonas aeruginosa.
    Rodríguez-Tebar A; Rojo F; Dámaso D; Vázquez D
    Antimicrob Agents Chemother; 1982 Aug; 22(2):255-61. PubMed ID: 6821456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
    Leying HJ; Büscher KH; Cullmann W; Then RL
    Chemotherapy; 1992; 38(2):82-91. PubMed ID: 1591950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of CGP 31608, a new penem.
    Wise R; Andrews JM; Piddock LJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):267-73. PubMed ID: 3105451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of beta-lactamase in in vivo development of ceftazidime resistance in experimental Pseudomonas aeruginosa endocarditis.
    Bayer AS; Peters J; Parr TR; Chan L; Hancock RE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):253-8. PubMed ID: 3105450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein.
    Büscher KH; Cullmann W; Dick W; Opferkuch W
    Antimicrob Agents Chemother; 1987 May; 31(5):703-8. PubMed ID: 3111361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of inner-membrane-associated beta-lactamase on penicillin-binding protein assays. Study of stably derepressed Pseudomonas aeruginosa strains from experimental endocarditis.
    Parr TR; Chan L; Bayer AS
    Chemotherapy; 1988; 34(6):478-83. PubMed ID: 3149570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
    Ubukata K; Hikida M; Yoshida M; Nishiki K; Furukawa Y; Tashiro K; Konno M; Mitsuhashi S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between lipopolysaccharide structure and permeability resistance in beta-lactam-resistant Pseudomonas aeruginosa.
    Godfrey AJ; Hatlelid L; Bryan LE
    Antimicrob Agents Chemother; 1984 Aug; 26(2):181-6. PubMed ID: 6435513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure activity relationships in PIPC-analogues against Pseudomonas aeruginosa.
    Mitsuyama J; Hori R; Ito Y; Yotsuji A; Yasuda T; Saikawa I
    J Antibiot (Tokyo); 1989 Apr; 42(4):598-603. PubMed ID: 2498272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics.
    Parr TR; Bryan LE
    Antimicrob Agents Chemother; 1984 Jun; 25(6):747-53. PubMed ID: 6611136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci.
    Kitzis MD; Acar JF; Gutmann L
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes.
    Sumita Y; Fukasawa M; Okuda T
    J Antibiot (Tokyo); 1990 Mar; 43(3):314-20. PubMed ID: 2108953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of the novel penem CGP 31 608 and its enantiomer with type Id beta-lactamase and penicillin-binding proteins.
    Mett H; Schacher B; Schneider P; Zak O
    Eur J Clin Microbiol; 1987 Dec; 6(6):674-8. PubMed ID: 3126060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penicillin-binding proteins of Pseudomonas aeruginosa. Comparison of two strains differing in their resistance to beta-lactam antibiotics.
    Curtis NA; Orr D; Boulton MG; Ross GW
    J Antimicrob Chemother; 1981 Feb; 7(2):127-36. PubMed ID: 6783607
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of permeability barriers in resistance to beta-lactam antibiotics.
    Nikaido H
    Pharmacol Ther; 1985; 27(2):197-231. PubMed ID: 2412244
    [No Abstract]   [Full Text] [Related]  

  • 36. Permeability and penicillin-binding protein alterations in Salmonella muenchen: stepwise resistance acquired during beta-lactam therapy.
    Bellido F; Vladoïanu IR; Auckenthaler R; Suter S; Wacker P; Then RL; Pechère JC
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1113-5. PubMed ID: 2782862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosa.
    Margaret BS; Drusano GL; Standiford HC
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():161-7. PubMed ID: 2509413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Carbapenem antibiotics].
    Watanabe A
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():737-43. PubMed ID: 12722309
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
    Livermore DM; Yang YJ
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii.
    Fernández-Cuenca F; Martínez-Martínez L; Conejo MC; Ayala JA; Perea EJ; Pascual A
    J Antimicrob Chemother; 2003 Mar; 51(3):565-74. PubMed ID: 12615856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.